Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome (ANI-ALGO)

Hopital Foch

Status: Completed

Conditions: Complex Regional Pain Syndrome

Treatments: Drug: Ropivacaine 0.5%

Study type: Interventional

Funder types: Other

Identifiers

NCT02663284

2011-A01676-35 (Other Identifier)

2011/67

Details and patient eligibility

About

A French University team (M. Jeanne, MD, and M. LOGIER, Ph D) have developed a pain assessment tool based on the analysis of the variability heart rate which evaluates the Analgesia Nociception Index (ANI). This index is intended to give a quantification of pain.

The aim of the present study is to assess the validity of the ANI parameter in patients with Complex Regional Pain Syndrome treated with a nerve block (reversible pain).

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients suffering from a Complex Regional Pain Syndrome of the upper or lower limb

Exclusion criteria

• contra-indication of a nerve block,
• contra-indication of the use of the pain monitor

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Perineural block

Experimental group

Description:

Perineural block with Ropivacaine 0.5%

Treatment:

Drug: Ropivacaine 0.5%